Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
The Department of War is required to establish an integrated pharmacy benefits program for the Military Health System, involving the selection of pharmaceutical agents for the Uniform Formulary (UF) based on clinical and cost effectiveness. A Request for Quotation (RFQ) has been issued for drug classes under review, with potential awards of Uniform Formulary Blanket Purchase Agreements (UF BPA) and Additional Discount Program Agreements (UF ADP). The P&T Committee will review several newly approved drugs in August 2026, including agents for ADHD, diuretics, antidepressants, and other conditions. A pre-quotation teleconference is scheduled for July 15, 2026, with details provided in the RFQ. Performance location and specific budget amounts are not specified in the description.